Skip to main content
SpringerLink
Log in

Malignant Skin Tumors in Children

  • Chapter
  • First Online:
Pediatric Malignancies: Pathology and Imaging

  • 2173 Accesses

Abstract

Primary skin malignancies are uncommon in children, and both benign and metastatic tumors surpass them in frequency. However, the resulting low index of suspicion may lead to a delay in diagnosis and treatment. Underlying factors associated with skin malignancies in children include giant congenital melanocytic nevi, xeroderma pigmentosum, albinism, Gorlin syndrome, immunodeficiency disorders, radiotherapy, and bone marrow and solid organ transplantation, among others [1–3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ceballos PI, Ruiz-Maldonado R, Mihm MC. Melanoma in children. N Engl J Med. 1995;332(10):656–62.

    CAS  PubMed  Google Scholar 

  2. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(13):975–83.

    CAS  PubMed  Google Scholar 

  3. Varan A, Gököz A, Akyüz C, et al. Primary malignant skin tumors in children: etiology, treatment and prognosis. Pediatr Int. 2005;47(6):653–7.

    PubMed  Google Scholar 

  4. Tatiana KSC, Somers GR, Pope E, Zuker RM. Predisposing factors and outcomes of malignant skin tumors in children. Plast Reconstr Surg. 2010;126(2):508–14.

    Google Scholar 

  5. Hamre MR, Chuba P, Bakhshi S, Thomas R, Severson RK. Cutaneous melanoma in childhood and adolescence. Pediatr Hematol Oncol. 2002;19(5):309–17.

    PubMed  Google Scholar 

  6. DiGiovanna JJ, Kraemer KH. Shining a light on xeroderma pigmentosum. J Invest Dermatol. 2012;132(3 Pt 2):785–96.

    PubMed Central  CAS  PubMed  Google Scholar 

  7. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987;123(2):241–50.

    CAS  PubMed  Google Scholar 

  8. Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol. 1994;130(8):1018–21.

    CAS  PubMed  Google Scholar 

  9. Bootsma D, Weeda G, Vermeulen W, et al. Nucleotide excision repair syndromes: molecular basis and clinical symptoms. Philos Trans R Soc Lond B Biol Sci. 1995;347(1319):75–81.

    CAS  PubMed  Google Scholar 

  10. Lynch HT, Anderson DE, Smith JL, Howell JB, Krush AJ. Xeroderma pigmentosum, malignant melanoma, and congenital ichthyosis. A family study. Arch Dermatol. 1967;96(6):625–35.

    CAS  PubMed  Google Scholar 

  11. Tsao H. Update on familial cancer syndromes and the skin. J Am Acad Dermatol. 2000;42(6):939–69. quiz 970–2.

    CAS  PubMed  Google Scholar 

  12. Goldstein AM, Chan M, Harland M, et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet. 2007;44(2):99–106.

    PubMed Central  CAS  PubMed  Google Scholar 

  13. Kanzler MH, Swetter SM. Malignant melanoma. J Am Acad Dermatol. 2003;48(5):780–3.

    PubMed  Google Scholar 

  14. Thieu K, Tsao H. Pigmentary abnormalities. In: Schachner L, Hansen RC, editors. Pediatric dermatology. 4th ed. Mosby Elsevier; 2011:734–46.

    Google Scholar 

  15. Fan Z, Li J, Du J, et al. A missense mutation in PTCH2 underlies dominantly inherited NBCCS in a Chinese family. J Med Genet. 2008;45(5):303–8.

    CAS  PubMed  Google Scholar 

  16. Pastorino L, Ghiorzo P, Nasti S, et al. Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am J Med Genet A. 2009;149A(7):1539–43.

    CAS  PubMed  Google Scholar 

  17. Lo Muzio L. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis. 2008;3:32.

    PubMed Central  PubMed  Google Scholar 

  18. Lindström E, Shimokawa T, Toftgård R, Zaphiropoulos PG. PTCH mutations: distribution and analyses. Hum Mutat. 2006;27(3):215–9.

    PubMed  Google Scholar 

  19. LeBoit PE, Burg G, Weedon D, Sarasain A. World Health Organization classification of tumours. Pathology and genetics of skin tumours. Lyon: IARC Press; 2006.

    Google Scholar 

  20. Gorlin RJ. Nevoid basal cell carcinoma syndrome. Dermatol Clin. 1995;13(1):113–25.

    CAS  PubMed  Google Scholar 

  21. Scobie WG, Preston J. Basal cell carcinoma in children. J R Coll Surg Edinb. 1992;37(1):46–7.

    CAS  PubMed  Google Scholar 

  22. Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med. 2004;6(6):530–9.

    PubMed  Google Scholar 

  23. Go JW, Kim SH, Yi SY, Cho HK. Basal cell nevus syndrome showing several histologic types of Basal cell carcinoma. Ann Dermatol. 2011;23 Suppl 1:S36–40.

    PubMed Central  PubMed  Google Scholar 

  24. Cajaiba MM, Bale AE, Alvarez-Franco M, McNamara J, Reyes-Múgica M. Rhabdomyosarcoma, Wilms tumor, and deletion of the patched gene in Gorlin syndrome. Nat Clin Pract Oncol. 2006;3(10):575–80.

    CAS  PubMed  Google Scholar 

  25. Mills O, Messina JL. Pediatric melanoma: a review. Cancer Control. 2009;16(3):225–33.

    PubMed  Google Scholar 

  26. Hill SJ, Delman KA. Pediatric melanomas and the atypical spitzoid melanocytic neoplasms. Am J Surg. 2011;203(6):761–7.

    PubMed  Google Scholar 

  27. Strouse JJ, Fears TR, Tucker MA, Wayne AS. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol. 2005;23(21):4735–41.

    PubMed  Google Scholar 

  28. Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer. 2008;112(2):416–32.

    PubMed  Google Scholar 

  29. Pappo AS. Melanoma in children and adolescents. Eur J Cancer. 2003;39(18):2651–61.

    CAS  PubMed  Google Scholar 

  30. Neier M, Pappo A, Navid F. Management of melanomas in children and young adults. J Pediatr Hematol Oncol. 2012;34 Suppl 2:S51–4.

    PubMed  Google Scholar 

  31. Landi MT, Bauer J, Pfeiffer RM, et al. MC1R germline variants confer risk for BRAF-mutant melanoma. Science. 2006;313(5786):521–2.

    CAS  PubMed  Google Scholar 

  32. Uribe P, Wistuba II, Solar A, Balestrini C, Perez-Cotapos ML, Gonzalez S. Comparative analysis of loss of heterozygosity and microsatellite instability in adult and pediatric melanoma. Am J Dermatopathol. 2005;27(4):279–85.

    PubMed  Google Scholar 

  33. Whiteman DC, Valery P, McWhirter W, Green AC. Risk factors for childhood melanoma in Queensland, Australia. Int J Cancer. 1997;70(1):26–31.

    CAS  PubMed  Google Scholar 

  34. Downard CD, Rapkin LB, Gow KW. Melanoma in children and adolescents. Surg Oncol. 2007;16(3):215–20.

    PubMed  Google Scholar 

  35. Rivers JK, Frederiksen PC, Dibdin C. A prevalence survey of dermatoses in the Australian neonate. J Am Acad Dermatol. 1990;23(1):77–81.

    CAS  PubMed  Google Scholar 

  36. Reyes-Múgica M, Beckwith M, Etchevers H. Etiology of Congenital Melanocytic Nevi and Related Conditions. In: Margoob A. Nevogenesis. Ch. 7;pp.73-97. Springer, 2012, New York.

    Google Scholar 

  37. Krengel S, Scope A, Dusza SW, Vonthein R, Marghoob AA. New recommendation for the categorization of cutaneous features of congenital melanocytic nevi. J Am Acad Dermatol. 2013;68(3):441–51.

    PubMed  Google Scholar 

  38. Wyatt AJ, Hansen RC. Pediatric skin tumors. Pediatr Clin North Am. 2000;47(4):937–63.

    CAS  PubMed  Google Scholar 

  39. Castilla EE, da Graça Dutra M, Orioli-Parreiras IM. Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies. Br J Dermatol. 1981;104(3):307–15.

    CAS  PubMed  Google Scholar 

  40. Lefkowitz A, Schwartz RA, Janniger CK. Melanoma precursors in children. Cutis. 1999;63(6):321–4.

    CAS  PubMed  Google Scholar 

  41. Tannous ZS, Mihm MC, Sober AJ, Duncan LM. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol. 2005;52(2):197–203.

    PubMed  Google Scholar 

  42. Marghoob AA. Congenital melanocytic nevi. Evaluation and management. Dermatol Clin. 2002;20(4):607–16. viii.

    PubMed  Google Scholar 

  43. Ruiz-Maldonado R, del Rosario Barona-Mazuera M, Hidalgo-Galván LR, et al. Giant congenital melanocytic nevi, neurocutaneous melanosis and neurological alterations. Dermatology. 1997;195(2):125–8.

    CAS  PubMed  Google Scholar 

  44. Krengel S, Hauschild A, Schäfer T. Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol. 2006;155(1):1–8.

    CAS  PubMed  Google Scholar 

  45. Hale EK, Stein J, Ben-Porat L, et al. Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi – results from the NYU-LCMN registry. Br J Dermatol. 2005;152(3):512–7.

    CAS  PubMed  Google Scholar 

  46. Mark GJ, Mihm MC, Liteplo MG, Reed RJ, Clark WH. Congenital melanocytic nevi of the small and garment type. Clinical, histologic, and ultrastructural studies. Hum Pathol. 1973;4(3):395–418.

    CAS  PubMed  Google Scholar 

  47. Barnhill RL, Fleischli M. Histologic features of congenital melanocytic nevi in infants 1 year of age or younger. J Am Acad Dermatol. 1995;33(5 Pt 1):780–5.

    CAS  PubMed  Google Scholar 

  48. Rhodes AR, Silverman RA, Harrist TJ, Melski JW. A histologic comparison of congenital and acquired nevomelanocytic nevi. Arch Dermatol. 1985;121(10):1266–73.

    CAS  PubMed  Google Scholar 

  49. McElearney ST, Dengel LT, Vaughters ABR, Patterson JW, McGahren ED, Slingluff CL. Neonatal congenital malignant melanoma with lymph node metastasis. J Clin Oncol. 2009;27(16):2726–8.

    PubMed  Google Scholar 

  50. Huynh PM, Grant-Kels JM, Grin CM. Childhood melanoma: update and treatment. Int J Dermatol. 2005;44(9):715–23.

    PubMed  Google Scholar 

  51. Valenzano Menada M, Moioli M, Garaventa A, et al. Spontaneous regression of transplacental metastases from maternal melanoma in a newborn: case report and review of the literature. Melanoma Res. 2010;20(6):443–9.

    PubMed  Google Scholar 

  52. Boddie AW, Smith JL, McBride CM. Malignant melanoma in children and young adults: effect of diagnostic criteria on staging and end results. South Med J. 1978;71(9):1074–8.

    PubMed  Google Scholar 

  53. Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics. 2005;115(3):649–54.

    PubMed  Google Scholar 

  54. Barnhill RL. Childhood melanoma. Semin Diagn Pathol. 1998;15(3):189–94.

    CAS  PubMed  Google Scholar 

  55. Barnhill RL, Flotte TJ, Fleischli M, Perez-Atayde A. Cutaneous melanoma and atypical Spitz tumors in childhood. Cancer. 1995;76(10):1833–45.

    CAS  PubMed  Google Scholar 

  56. Livestro DP, Kaine EM, Michaelson JS, et al. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer. 2007;110(3):614–24.

    PubMed  Google Scholar 

  57. Akyürek M, Kayikçioğlu A, Ozkan O, Güler G, Mavili E, Erk Y. Multiple agminated Spitz nevi of the scalp. Ann Plast Surg. 1999;43(4):459–60.

    PubMed  Google Scholar 

  58. Böer A, Wolter M, Kneisel L, Kaufmann R. Multiple agminated Spitz nevi arising on a café au lait macule: review of the literature with contribution of another case. Pediatr Dermatol. 2001;18(6):494–7.

    PubMed  Google Scholar 

  59. Bullen R, Snow SN, Larson PO, Kircik LH, Nychay S, Briggs P. Multiple agminated Spitz nevi: report of two cases and review of the literature. Pediatr Dermatol. 1995;12(2):156–8.

    CAS  PubMed  Google Scholar 

  60. Hueso L, Hernández A, Torrelo A, Colmenero I, Zambrano A. Agminated Spitz nevi on a hyperpigmented macule. Actas Dermosifiliogr. 2008;99(1):69–72.

    CAS  PubMed  Google Scholar 

  61. Levy RM, Ming ME, Shapiro M, et al. Eruptive disseminated Spitz nevi. J Am Acad Dermatol. 2007;57(3):519–23.

    PubMed  Google Scholar 

  62. Fass J, Grimwood RE, Kraus E, Hyman J. Adult onset of eruptive widespread Spitz’s nevi. J Am Acad Dermatol. 2002;46 Suppl 5:S142–3.

    PubMed  Google Scholar 

  63. Walsh N, Crotty K, Palmer A, McCarthy S. Spitz nevus versus spitzoid malignant melanoma: an evaluation of the current distinguishing histopathologic criteria. Hum Pathol. 1998;29(10):1105–12.

    CAS  PubMed  Google Scholar 

  64. Busam KJ, Barnhill RL. Pagetoid Spitz nevus. Intraepidermal Spitz tumor with prominent pagetoid spread. Am J Surg Pathol. 1995;19(9):1061–7.

    CAS  PubMed  Google Scholar 

  65. Requena C, Botella R, Nagore E, et al. Characteristics of spitzoid melanoma and clues for differential diagnosis with spitz nevus. Am J Dermatopathol. 2012;34(5):478–86.

    PubMed  Google Scholar 

  66. Crotty KA, Scolyer RA, Li L, Palmer AA, Wang L, McCarthy SW. Spitz naevus versus Spitzoid melanoma: when and how can they be distinguished? Pathology. 2002;34(1):6–12.

    PubMed  Google Scholar 

  67. Massi G. Melanocytic nevi simulant of melanoma with medicolegal relevance. Virchows Arch. 2007;451(3):623–47.

    PubMed  Google Scholar 

  68. Kapur P, Selim MA, Roy LC, Yegappan M, Weinberg AG, Hoang MP. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis. Mod Pathol. 2005;18(2):197–204.

    CAS  PubMed  Google Scholar 

  69. Bergman R, Dromi R, Trau H, Cohen I, Lichtig C. The pattern of HMB-45 antibody staining in compound Spitz nevi. Am J Dermatopathol. 1995;17(6):542–6.

    CAS  PubMed  Google Scholar 

  70. Kanter-Lewensohn L, Hedblad MA, Wejde J, Larsson O. Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas. Mod Pathol. 1997;10(9):917–20.

    CAS  PubMed  Google Scholar 

  71. Palazzo J, Duray PH. Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study. Hum Pathol. 1989;20(4):341–6.

    CAS  PubMed  Google Scholar 

  72. Ribé A, McNutt NS. S100A6 protein expression is different in Spitz nevi and melanomas. Mod Pathol. 2003;16(5):505–11.

    PubMed  Google Scholar 

  73. Li LX, Crotty KA, McCarthy SW, Palmer AA, Kril JJ. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions. Am J Dermatopathol. 2000;22(6):489–95.

    CAS  PubMed  Google Scholar 

  74. Blokx WAM, van Dijk MCRF, Ruiter DJ. Molecular cytogenetics of cutaneous melanocytic lesions – diagnostic, prognostic and therapeutic aspects. Histopathology. 2010;56(1):121–32.

    PubMed  Google Scholar 

  75. Gerami P, Li G, Pouryazdanparast P, et al. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Am J Surg Pathol. 2012;36(6):808–17.

    PubMed  Google Scholar 

  76. Spatz A, Calonje E, Handfield-Jones S, Barnhill RL. Spitz tumors in children: a grading system for risk stratification. Arch Dermatol. 1999;135(3):282–5.

    CAS  PubMed  Google Scholar 

  77. Barnhill RL, Argenyi ZB, From L, et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol. 1999;30(5):513–20.

    CAS  PubMed  Google Scholar 

  78. Barnhhill R. Childhood melanoma. In: LeBoit P, Burg G, Weedon D, Sarasain A, editors. World Health Organization classification of tumours: pathology and genetics of skin tumours. Lyon: IARC Press; 2006. p. 84–5.

    Google Scholar 

  79. Smith KJ, Barrett TL, Skelton HG, Lupton GP, Graham JH. Spindle cell and epithelioid cell nevi with atypia and metastasis (malignant Spitz nevus). Am J Surg Pathol. 1989;13(11):931–9.

    CAS  PubMed  Google Scholar 

  80. Ludgate MW, Fullen DR, Lee J, et al. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer. 2009;115(3):631–41.

    PubMed  Google Scholar 

  81. Wiesner T, Obenauf AC, Murali R, et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet. 2011;43(10):1018–21.

    PubMed Central  CAS  PubMed  Google Scholar 

  82. Wiesner T, Murali R, Fried I, et al. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol. 2012;36(6):818–30.

    PubMed Central  PubMed  Google Scholar 

  83. Ferrara G, Argenziano G, Soyer HP, et al. The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol. 2005;141(11):1381–7.

    PubMed  Google Scholar 

  84. Sau P, Graham JH, Helwig EB. Pigmented spindle cell nevus: a clinicopathologic analysis of ninety-five cases. J Am Acad Dermatol. 1993;28(4):565–71.

    CAS  PubMed  Google Scholar 

  85. Sagebiel RW, Chinn EK, Egbert BM. Pigmented spindle cell nevus. Clinical and histologic review of 90 cases. Am J Surg Pathol. 1984;8(9):645–53.

    CAS  PubMed  Google Scholar 

  86. Phadke PA, Rakheja D, Le LP, et al. Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases. Am J Surg Pathol. 2011;35(5):656–69.

    PubMed  Google Scholar 

  87. Gimotty PA, Botbyl J, Soong S-J, Guerry D. A population-based validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2005;23(31):8065–75.

    PubMed  Google Scholar 

  88. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355(13):1307–17.

    CAS  PubMed  Google Scholar 

  89. Roaten JB, Partrick DA, Pearlman N, Gonzalez RJ, Gonzalez R, McCarter MD. Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents. J Pediatr Surg. 2005;40(1):232–5.

    PubMed  Google Scholar 

  90. Coit DG, Andtbacka R, Anker CJ, et al. Melanoma, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013;11(4):395–407.

    CAS  PubMed  Google Scholar 

  91. Parida L, Morrisson GT, Shammas A, et al. Role of lymphoscintigraphy and sentinel lymph node biopsy in the management of pediatric melanoma and sarcoma. Pediatr Surg Int. 2012;28(6):571–8.

    PubMed Central  PubMed  Google Scholar 

  92. Vidal M, Vidal-Sicart S, Torrents A, et al. Accuracy and reproducibility of lymphoscintigraphy for sentinel node detection in patients with cutaneous melanoma. J Nucl Med. 2012;53(8):1193–9.

    PubMed  Google Scholar 

  93. Alazraki N, Glass EC, Castronovo F, Olmos RAV, Podoloff D. Procedure guideline for lymphoscintigraphy and the use of intraoperative gamma probe for sentinel lymph node localization in melanoma of intermediate thickness 1.0. J Nucl Med. 2002;43(10):1414–8.

    PubMed  Google Scholar 

  94. Wagner T, Buscombe J, Gnanasegaran G, Navalkissoor S. SPECT/CT in sentinel node imaging. Nucl Med Commun. 2013;34(3):191–202.

    CAS  PubMed  Google Scholar 

  95. Schröer-Günther MA, Wolff RF, Westwood ME, et al. F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review. Syst Rev. 2012;1:62.

    PubMed Central  PubMed  Google Scholar 

  96. Wagner T, Chevreau C, Meyer N, Mourey L, Courbon F, Zerdoud S. Routine FDG PET-CT in patients with a high-risk localized melanoma has a high predictive positive value for nodal disease and high negative predictive value for the presence of distant metastases. J Eur Acad Dermatol Venereol. 2012;26(11):1431–5.

    CAS  PubMed  Google Scholar 

  97. Bronstein Y, Ng CS, Rohren E, et al. PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging. Am J Roentgenol. 2012;198(4):902–8.

    Google Scholar 

  98. Jouvet JC, Thomas L, Thomson V, et al. Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study. J Eur Acad Dermatol Venereol. 2014;28(2):176–85.

    Google Scholar 

  99. Landau JM, Moody MN, Goldberg LH, Vergilis-Kalner IJ. An unusual presentation of idiopathic basal cell carcinoma in an 8-year-old child. Pediatr Dermatol. 2012;29(3):379–81.

    PubMed  Google Scholar 

  100. Dinehart SM, Dodge R, Stanley WE, Franks HH, Pollack SV. Basal cell carcinoma treated with Mohs surgery. A comparison of 54 younger patients with 1050 older patients. J Dermatol Surg Oncol. 1992;18(7):560–6.

    CAS  PubMed  Google Scholar 

  101. Ademiluyi SA, Ijaduola GT. Occurrence and recurrence of basal cell carcinoma of the head and neck in Negroid and albinoid Africans. J Laryngol Otol. 1987;101(12):1324–8.

    CAS  PubMed  Google Scholar 

  102. Abuzahra F, Parren LJMT, Frank J. Multiple familial and pigmented basal cell carcinomas in early childhood – Bazex-Dupré-Christol syndrome. J Eur Acad Dermatol Venereol. 2012;26(1):117–21.

    CAS  PubMed  Google Scholar 

  103. Griffin JR, Cohen PR, Tschen JA, et al. Basal cell carcinoma in childhood: case report and literature review. J Am Acad Dermatol. 2007;57 Suppl 5:S97–102.

    PubMed  Google Scholar 

  104. Rosen H, Schmidt B, Lam HP, Meara JG, Labow BI. Management of nevus sebaceous and the risk of Basal cell carcinoma: an 18-year review. Pediatr Dermatol. 2009;26(6):676–81.

    PubMed  Google Scholar 

  105. Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol. 2011;65(2):253–61. quiz 262.

    PubMed  Google Scholar 

  106. Lehmann AR, McGibbon D, Stefanini M. Xeroderma pigmentosum. Orphanet J Rare Dis. 2011;6(1):70.

    PubMed Central  PubMed  Google Scholar 

  107. Magnaldo T, Sarasin A. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy. Cells Tissues Organs. 2004;177(3):189–98.

    PubMed  Google Scholar 

  108. Sattler E, Räwer H-C, Mühlstädt M, Ruzicka T, Burgdorf W, Kunte C. Basal cell carcinomas in radiotherapy-treated port wine stains. An ideal indication for Mohs surgery. Hautarzt. 2011;62(7):534–8.

    CAS  PubMed  Google Scholar 

  109. Paulino AC, Fowler BZ. Secondary neoplasms after radiotherapy for a childhood solid tumor. Pediatr Hematol Oncol. 2005;22(2):89–101.

    PubMed  Google Scholar 

  110. Hassanpour SE, Kalantar-Hormozi A, Motamed S, Moosavizadeh SM, Shahverdiani R. Basal cell carcinoma of scalp in patients with history of childhood therapeutic radiation: a retrospective study and comparison to nonirradiated patients. Ann Plast Surg. 2006;57(5):509–12.

    CAS  PubMed  Google Scholar 

  111. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353(21):2262–9.

    CAS  PubMed  Google Scholar 

  112. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol. 1990;23(6 Pt 1):1118–26.

    CAS  PubMed  Google Scholar 

  113. Batra RS, Kelley LC. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol. 2002;138(8):1043–51.

    PubMed  Google Scholar 

  114. Ackerman AB. Nevoid basal cell carcinoma syndrome versus generalized basaloid follicular hamartoma syndrome. J Cutan Pathol. 2009;36(5):603. doi:10.1111/j.1600-0560.2008.01097.x. author reply 604.

    CAS  PubMed  Google Scholar 

  115. Ramos-Ceballos FI, Pashaei S, Kincannon JM, Morgan MB, Smoller BR. Bcl-2, CD34 and CD10 expression in basaloid follicular hamartoma, vellus hair hamartoma and neurofollicular hamartoma demonstrate full follicular differentiation. J Cutan Pathol. 2008;35(5):477–83.

    PubMed  Google Scholar 

  116. Burgdorf W, Gerami P, Yan A. Bening and malignant tumors. In: Schachner L, Hansen R, editors. Pediatric dermatology. 4th ed. Mosby Elsevier; 2011:1181–216.

    Google Scholar 

  117. Amonette RA, Salasche SJ, Chesney TM, Clarendon CC, Dilawari RA. Metastatic basal-cell carcinoma. J Dermatol Surg Oncol. 1981;7(5):397–400.

    CAS  PubMed  Google Scholar 

  118. Taskinen M, Ranki A, Pukkala E, Jeskanen L, Kaitila I, Mäkitie O. Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma. Am J Med Genet A. 2008;146A(18):2370–5.

    PubMed  Google Scholar 

  119. Cowen EW, Nguyen JC, Miller DD, et al. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole. J Am Acad Dermatol. 2010;62(1):31–7.

    PubMed Central  CAS  PubMed  Google Scholar 

  120. Orth G. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. Curr Top Microbiol Immunol. 2008;321:59–83.

    CAS  PubMed  Google Scholar 

  121. Kaspar TA, Wagner RF, Jablonska S, Niimura M, Tyring SK. Prognosis and treatment of advanced squamous cell carcinoma secondary to epidermodysplasia verruciformis: a worldwide analysis of 11 patients. J Dermatol Surg Oncol. 1991;17(3):237–40.

    CAS  PubMed  Google Scholar 

  122. Kotwal A, Watt D. Cutaneous squamous cell carcinoma in a child. J Plast Reconstr Aesthet Surg. 2009;62(7):e194–5.

    CAS  PubMed  Google Scholar 

  123. Pearce MS, Parker L, Cotterill SJ, Gordon PM, Craft AW. Skin cancer in children and young adults: 28 years’ experience from the Northern Region Young Person’s Malignant Disease Registry, UK. Melanoma Res. 2003;13(4):421–6.

    PubMed  Google Scholar 

  124. Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–90.

    CAS  PubMed  Google Scholar 

  125. Czarnecki D, Staples M, Mar A, Giles G, Meehan C. Metastases from squamous cell carcinoma of the skin in southern Australia. Dermatology. 1994;189(1):52–4.

    CAS  PubMed  Google Scholar 

  126. Jackson A. Prevention, early detection and team management of skin cancer in primary care: contribution to the health of the nation objectives. Br J Gen Pract. 1995;45(391):97–101.

    PubMed Central  CAS  PubMed  Google Scholar 

  127. Kwa RE, Campana K, Moy RL. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;26(1):1–26.

    CAS  PubMed  Google Scholar 

  128. Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol. 1992;26(3 Pt 2):467–84.

    CAS  PubMed  Google Scholar 

  129. Anon. Guidelines of care for cutaneous squamous cell carcinoma. Committee on Guidelines of Care. Task Force on Cutaneous Squamous Cell Carcinoma. J Am Acad Dermatol. 1993;28(4):628–31.

    Google Scholar 

  130. Holmkvist KA, Roenigk RK. Squamous cell carcinoma of the lip treated with Mohs micrographic surgery: outcome at 5 years. J Am Acad Dermatol. 1998;38(6 Pt 1):960–6.

    CAS  PubMed  Google Scholar 

  131. Novick M, Gard DA, Hardy SB, Spira M. Burn scar carcinoma: a review and analysis of 46 cases. J Trauma. 1977;17(10):809–17.

    CAS  PubMed  Google Scholar 

  132. Fine J-D, Johnson LB, Weiner M, Li K-P, Suchindran C. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986–2006. J Am Acad Dermatol. 2009;60(2):203–11.

    PubMed  Google Scholar 

  133. Love RL, Breidahl AF. Acute squamous cell carcinoma arising within a recent burn scar in a 14-year-old boy. Plast Reconstr Surg. 2000;106(5):1069–71.

    CAS  PubMed  Google Scholar 

  134. Lawrence N, Cottel WI. Squamous cell carcinoma of skin with perineural invasion. J Am Acad Dermatol. 1994;31(1):30–3.

    CAS  PubMed  Google Scholar 

  135. Maher-Wiese VL, Wenner NP, Grant-Kels JM. Metastatic cutaneous lesions in children and adolescents with a case report of metastatic neuroblastoma. J Am Acad Dermatol. 1992;26(4):620–8.

    CAS  PubMed  Google Scholar 

  136. De la Luz Orozco-Covarrubias M, Tamayo-Sanchez L, Duran-McKinster C, Ridaura C, Ruiz-Maldonado R. Malignant cutaneous tumors in children. Twenty years of experience at a large pediatric hospital. J Am Acad Dermatol. 1994;30(2 Pt 1):243–9.

    PubMed  Google Scholar 

  137. Van Erp IF. Cutaneous metastases in neuroblastoma. Dermatologica. 1968;136(4):265–9.

    PubMed  Google Scholar 

  138. Hawthorne HC, Nelson JS, Witzleben CL, Giangiacomo J. Blanching subcutaneous nodules in neonatal neuroblastoma. J Pediatr. 1970;77(2):297–300.

    PubMed  Google Scholar 

  139. Lucky AW, McGuire J, Komp DM. Infantile neuroblastoma presenting with cutaneous blanching nodules. J Am Acad Dermatol. 1982;6(3):389–91.

    CAS  PubMed  Google Scholar 

  140. Mehta V, Balachandran C, Lonikar V. Blueberry muffin baby: a pictoral differential diagnosis. Dermatol Online J. 2008;14(2):8.

    PubMed  Google Scholar 

  141. Brecher AR, Reyes-Mugica M, Kamino H, Chang MW. Congenital primary cutaneous rhabdomyosarcoma in a neonate. Pediatr Dermatol. 2003;20(4):335–8.

    PubMed  Google Scholar 

  142. Nesbit ME. Advances and management of solid tumors in children. Cancer. 1990;65 Suppl 3:696–702.

    PubMed  Google Scholar 

  143. Wiss K, Solomon AR, Raimer SS, Lobe TE, Gourley W, Headington JT. Rhabdomyosarcoma presenting as a cutaneous nodule. Arch Dermatol. 1988;124(11):1687–90.

    CAS  PubMed  Google Scholar 

  144. Isaacs H. Cutaneous metastases in neonates: a review. Pediatr Dermatol. 2011;28(2):85–93.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Birmingham Children’s Hospital, Steelhouse Ln, Birmingham, West Midlands, UK

    Isabel Colmenero M.D.

  2. St. Jude Children’s Research Hospital, Memphis, TN, USA

    M. Beth McCarville M.D.

  3. Children’s Hospital of Pittsburgh, UPMC, University of Pittsburgh School of Medicine, One Children’s Hospital Drive, 4401 Penn Avenue, Pittsburgh, PA, 15224, USA

    Miguel Reyes-Múgica M.D.

Authors
  1. Isabel Colmenero M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Beth McCarville M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miguel Reyes-Múgica M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Miguel Reyes-Múgica M.D. .

Editor information

Editors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles, University of Southern California, Los Angeles, California, USA

    David M. Parham

  2. Associate Professor of Pathology and Laboratory Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

    Joseph D. Khoury

  3. Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA

    M. Beth McCarville

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Colmenero, I., McCarville, M.B., Reyes-Múgica, M. (2015). Malignant Skin Tumors in Children. In: Parham, D., Khoury, J., McCarville, M. (eds) Pediatric Malignancies: Pathology and Imaging. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1729-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1729-7_13

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1728-0

  • Online ISBN: 978-1-4939-1729-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation